enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Antiplatelet drug - Wikipedia

    en.wikipedia.org/wiki/Antiplatelet_drug

    An antiplatelet drug (antiaggregant), also known as a platelet agglutination inhibitor or platelet aggregation inhibitor, is a member of a class of pharmaceuticals that decrease platelet aggregation [1] and inhibit thrombus formation.

  3. BRILINTA (Ticagrelor) Receives Additional Class I ... - AOL

    www.aol.com/news/2012-12-17-brilinta-ticagrelor...

    BRILINTA (Ticagrelor) Receives Additional Class I Recommendation in Updated ACCF/AHA Guidelines for the Management of STEMI Patients BRILINTA Recognized Across Major US Treatment Guidelines for ...

  4. Ticagrelor - Wikipedia

    en.wikipedia.org/wiki/Ticagrelor

    Ticagrelor, sold under the brand name Brilinta among others, is a medication used for the prevention of stroke, heart attack and other events in people with acute coronary syndrome, meaning problems with blood supply in the coronary arteries. It acts as a platelet aggregation inhibitor by antagonising the P2Y 12 receptor. [7]

  5. Bentracimab - Wikipedia

    en.wikipedia.org/wiki/Bentracimab

    Bentracimab is a monoclonal antibody medication which has been shown in phase one and two clinical trials to function as a reversal agent for the anti–blood clotting drug ticagrelor (which acts as a P2Y 12 inhibitor and is sold under the brand name Brilinta among others). [2]

  6. Adenosine diphosphate receptor inhibitor - Wikipedia

    en.wikipedia.org/wiki/Adenosine_diphosphate...

    Ticagrelor was the first reversible inhibitor of the P2Y 12 receptor, active after oral administration. Ticagrelor is orally active without the need for any metabolic activation. It is rapidly absorbed and undergoes enzymatic degradation to at least one active metabolite which is almost as potent as its parent compound. Ticagrelor has improved ...

  7. Calorie restriction plus common diabetes drug leads to higher ...

    www.aol.com/calorie-restriction-plus-common...

    Upon analysis, Li and his team found that after 12 months, 44% of study participants in the combination dapagliflozin and calorie restriction group achieved type 2 diabetes remission, compared to ...

  8. BRILINTA (ticagrelor) Launches "Complete the Course" — a ...

    www.aol.com/news/2012-09-19-brilinta-ticagrelor...

    For premium support please call: 800-290-4726 more ways to reach us more ways to reach us

  9. Ticlopidine - Wikipedia

    en.wikipedia.org/wiki/Ticlopidine

    Even higher absorption can occur if ticlopidine is taken with food. It is metabolized by the liver with both renal and fecal elimination. Clearance is nonlinear and varies with repeated dosing. After the first dose the half life is 12.6 hours, but with repeated dosing the maximum half life is 4–5 days. Clearance is also slower in the elderly.